Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Advertisements published for the Notice of Board Meeting to be held on 29th June, 2021, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2021, in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 24th June, 2021. Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window
In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, the 29th June, 2021 at 11:45 A.M. inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st April, 2021 till 48 hours of declaration of results i.e. 01st July, 2021 (both days inclusive). Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Considering Audited Financial Results For The Quarter And Year Ended March 31, 2021
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st April, 2021 till 48 hours of declaration of results i.e. 01st July, 2021 (both days inclusive). Genomic Valley Biotech Ltd - 539206 - Outcomes Of The Board Meeting
Pursuant to the Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited ('Company') in its meeting held today approved the authorization of Mr. Yogesh Agrawal, Managing Director, on behalf of the Company, to sell 5.43125 acres of land out of 9.06 acres of land of the company situated at 4 KM Stone, Berri Chhara Road, P.O. Tanda Heri, Tehsil- Bahadurgarh, District- Jhajjar, Haryana - 124507 alongwith all buildings and all temporary & permanent structure appurtenant thereto to One Point Realty Private Limited having Registered Office at 8-D, Hansalaya 15, Barakhamba Road, New Delhi - 110001 through its authorized persons. Genomic Valley Biotech Ltd - 539206 - Outcomes Of Board Meeting
Pursuant to the Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Archies Limited ('Company') in its meeting held today approved the authorization of Mr. Yogesh Agrawal, Managing Director, on behalf of the Company, to sell 5.43125 acres of land out of 9.06 acres of land of the company situated at 4 KM Stone, Berri Chhara Road, P.O. Tanda Heri, Tehsil- Bahadurgarh, District- Jhajjar, Haryana - 124507 alongwith all buildings and all temporary & permanent structure appurtenant thereto to One Point Realty Private Limited having Registered Office at 8-D, Hansalaya 15, Barakhamba Road, New Delhi - 110001 through its authorized persons. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that Mrs. Monisha Meghna (Membership No. A41747) has tendered his resignation from the post of Company Secretary and Compliance Officer of the Company with effect from 09.06.2021 by submitting his resignation letter dated 09.06.2021 to the Board of Directors of the Company. Resignation Letter (reason of resignation mentioned within) is attached herewith for your consideration. Genomic Valley Biotech Ltd - 539206 - Certificate Pursuant To Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the certificate pursuant to Regulation 40 (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half ended on 31st March, 2021. Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended March 31, 2021
Genomic Valley Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Yogesh AgrawalDesignation :- Managing Director / Whole Time Director Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 31st March, 2021.